Regeneron Pharma (REGN) PT Raised to $1,025 at BMO Capital
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $797.99 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 9
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Regeneron Pharma (NASDAQ: REGN) to $1,025.00 (from $1,001.00) while maintaining a Outperform rating.
You May Also Be Interested In
- salesforce.com (CRM) PT Raised to $222 at Monness, Crespi, Hardt
- Runway Growth Finance Corp. (RWAY) PT Raised to $11 at B.Riley
- Cisco (CSCO) PT Raised to $150 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
